コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 phase 1 trial of givosiran in patients with acute intermittent porphyria.
3 and disease manifestations in patients with acute intermittent porphyria, a rare inherited disease o
4 in symptomatic improvement in patients with acute intermittent porphyria (AIP) and porphyria cutanea
6 h porphyria cutanea tarda (PCT) and 296 with acute intermittent porphyria (AIP) were linked to the na
7 ydroxymethylbilane synthase (HMBS) can cause acute intermittent porphyria (AIP), an acute neurologica
8 lyze the urinary metabolome of patients with acute intermittent porphyria (AIP), an inherited metabol
9 al for hepatic enzymopenic disorders such as acute intermittent porphyria (AIP), an inherited porphob
14 cute porphyrias with neurovisceral symptoms: acute intermittent porphyria; delta amino-levulinic acid
18 rent and/or life-threatening acute attack in acute intermittent porphyria or acute liver failure or e
20 ing Alas1 (Alas1-siRNAs) in a mouse model of acute intermittent porphyria, the most common acute hepa
21 Deficiency in this enzyme activity causes acute intermittent porphyria, the most common disorder o